Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

<div>Construction of the KRAS-associated metabolic risk model for pancreatic cancer (PC). (a) Univariable and (b) multivariable Cox regression analyses to select prognosis-associated DEGs (PAGs). (c) Distribution of risk score and patient survival time and status of PC.</div>

BioMed Research International

fig4

Figure 4

Figure 4: Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer 